IN THIS ARTICLE

Citations

1. Roger VL, et al. (2010). Heart disease and stroke statistics 2011 update: A report from the American Heart Association. Circulation, 123(4): e18–e209.

2. Rossouw JE, et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297(13): 1465–1477.

3. U.S. Preventive Services Task Force (2009). Aspirin for the Prevention of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf09/aspirincvd/aspcvdrs.htm.

Other Works Consulted

• Charney P (2008). Women and coronary artery disease. In V Fuster et al., eds., Hurst's The Heart, 12th ed., pp. 2275–2290. New York: McGraw-Hill Medical.

• Hsia J, Manson JE (2007). Women and heart disease. In EJ Topol, ed., Textbook of Cardiovascular Medicine, 3rd ed., pp. 553–560. Philadelphia: Lippincott Williams and Wilkins.

• Mosca L, et al. (2011). Effectiveness-based guidelines for the prevention of cardiovascular disease in women 2011 update: A guideline from the American Heart Association. Circulation, 123(11): 1243–1262.

• Newby LK, Douglas PS (2008). Cardiovascular disease in women. In P Libby, ed., Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed., vol. 2, pp. 1955–1966. Philadelphia: Saunders Elsevier.

• U.S. Preventive Services Task Force (2009). Aspirin for the Prevention of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf09/aspirincvd/aspcvdrs.htm.